Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma

Journal of the American Academy of Dermatology

Volumn 59, Issue 2, 2008, Pages 245-254

  Gerami, Pedram ^a   Wickless, Scott C ^a   Rosen, Steve ^a   Kuzel, Timothy M ^a   Ciurea, Ana ^a   Havey, Jilian ^a   Guitart, Joan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DOXORUBICIN; DOXYCYCLINE; MINOCYCLINE; PREDNISONE; RITUXIMAB; STEROID; TRIAMCINOLONE ACETONIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; MYCOSIS FUNGOIDES; NODULAR LYMPHOMATOSIS; PAPULAR RASH; PRIORITY JOURNAL; RISK FACTOR; SEZARY SYNDROME; SKIN LYMPHOMA; SYSTEMIC DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILLINOIS; LYMPHOMA; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 47049111312     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.04.012     Document Type: Article

References (28)

1. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
2. Klein U., Kuppers R., and Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 89 (1997) 1288-1298
3. de la Fouchardiere A., Gazzo S., Balme B., Chouvet B., Felman P., Coiffier B., et al. Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas. Am J Dermatopathol 28 (2006) 287-292
4. Gallardo F., Bellosillo B., Espinet B., Pujol R.M., Estrach T., Servitje O., et al. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma. Hum Pathol 37 (2006) 867-873
5. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon
6. Mitterlechner T., Fiegl M., Muhlbock H., Oberaigner W., Dirnhofer S., and Tzankov A. Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000. J Clin Pathol 59 (2006) 48-55
7. Palmedo G., Hantschke M., Rutten A., Mentzel T., Kempf W., Tomasini D., et al. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?. Am J Dermatopathol 29 (2007) 231-236
8. Schreuder M.I., Hoefnagel J.J., Jansen P.M., van Krieken J.H., Willemze R., and Hebeda K.M. FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma. J Pathol 205 (2005) 302-310
9. Hoefnagel J.J., Vermeer M.H., Jansen P.M., Heule F., van Voorst Vader P.C., Sanders C.J., et al. Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases. Arch Dermatol 141 (2005) 1139-1145
10. Senff N.J., and Willemze R. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Br J Dermatol 157 (2007) 1205-1211
11. Kim Y.H., Willemze R., Pimpinelli N., Whittaker S., Olsen E.A., Ranki A., et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 (2007) 479-484
12. Cerroni L., Signoretti S., Hofler G., Annessi G., Putz B., Lackinger E., et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 21 (1997) 1307-1315
13. Baldassano M.F., Bailey E.M., Ferry J.A., Harris N.L., and Duncan L.M. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol 23 (1999) 88-96
14. Bergman R., Marcus-Farber B.S., Manov L., Nerodinisky I., Epelbaum R., Sahar D., et al. Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 years. Int J Dermatol 41 (2002) 735-743
15. de la Fouchardiere A., Balme B., Chouvet B., Sebban C., Perrot H., Claudy A., et al. Primary cutaneous marginal zone B-cell lymphoma: a report of 9 cases. J Am Acad Dermatol 41 (1999) 181-188
16. de Leval L., Harris N.L., Longtine J., Ferry J.A., and Duncan L.M. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification. Am J Surg Pathol 25 (2001) 732-741
17. Gronbaek K., Moller P.H., Nedergaard T., Thomsen K., Baadsgaard O., Hou-Jensen K., et al. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases. Br J Dermatol 142 (2000) 913-923
18. Li C., Inagaki H., Kuo T.T., Hu S., Okabe M., and Eimoto T. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases. Am J Surg Pathol 27 (2003) 1061-1069
19. Liu Q., Ohshima K., and Kikuchi M. Primary cutaneous B-cell lymphoma in Japanese patients. Pathol Int 50 (2000) 960-966
20. Magro C.M., Porcu P., Ahmad N., Klinger D., Crowson A.N., and Nuovo G. Cutaneous immunocytoma: a clinical, histologic, and phenotypic study of 11 cases. Appl Immunohistochem Mol Morphol 12 (2004) 216-224
21. Rijlaarsdam J.U., van der Putte S.C., Berti E., Kerl H., Rieger E., Toonstra J., et al. Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 23 (1993) 117-125
22. Sah A., Barrans S.L., Parapia L.A., Jack A.S., and Owen R.G. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients. Am J Hematol 75 (2004) 195-199
23. Servitje O., Gallardo F., Estrach T., Pujol R.M., Blanco A., Fernandez-Sevilla A., et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 147 (2002) 1147-1158
24. Smith B.D., Glusac E.J., McNiff J.M., Smith G.L., Heald P.W., Cooper D.L., et al. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems. J Clin Oncol 22 (2004) 634-639
25. Zinzani P.L., Quaglino P., Pimpinelli N., Berti E., Baliva G., Rupoli S., et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 24 (2006) 1376-1382
26. Bogle M.A., Riddle C.C., Triana E.M., Jones D., and Duvic M. Primary cutaneous B-cell lymphoma. J Am Acad Dermatol 53 (2005) 479-484
27. Senff N.J., Hoefnagel J.J., Neelis K.J., Vermeer M.H., Noordijk E.M., and Willemze R. Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 143 (2007) 1520-1526
28. Willemze R., Rijlaarsdam J.U., and Meijer C.J. Are most primary cutaneous B-cell lymphomas 'marginal cell lymphomas'?. Br J Dermatol 133 (1995) 950-952